Cell and Gene Therapy
A section of Cells (ISSN 2073-4409).
Section Information
Cell gene therapy involves two aspects: cell therapy and gene therapy. Cell therapy is a method that uses the patient's own or donor cells to stimulate an immune response or cell regeneration to kill pathogens and tumor cells. It includes immune cell therapy, stem cell therapy, and somatic cell therapy. Gene therapy is an approach based on treating disease via modifying (through introduction, removal, and change) the patient's genes. In the past few decades, the research on cell and gene therapy has developed rapidly and this is now emerging as an alternative therapy for many diseases.
The Section “Cell and Gene Therapy” aims to encourage research that focuses on the research progress of cell gene therapy in tumors, genetic diseases, cardiovascular diseases, autoimmune diseases, and some rare diseases. We welcome original research, review articles, communications, and technical notes on topics including, but not limited to, the following:
- Immunotherapy;
- Adoptive Cell Therapy;
- Stem Cell Therapy;
- CAR-T Cell Therapy
- Cell Culture;
- Tissue Engineering and Regenerative Medicine;
- Epigenetics and Stem Cell Biology;
- Genomic Medicine;
- Bioengineering and Therapeutic Sciences;
- Transgenic Animal Models;
- Immunogenetics;
- Transplantation and Immunology;
- Biomarkers;
- Viral Vector;
- Bacterial Vector;
- Genome Editing;
- Plasmid DNA;
- Oncolytic Virus;
- RNA Therapeutics;
- Vaccine.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Non-Coding and Coding RNAs in Targeted Cancer Therapy (Deadline: 25 May 2026)
- Gene Regulation in Epithelial Cells (Deadline: 30 June 2026)
- Interaction Between DNA Damage Response and Anti-Cancer Immunity (Deadline: 30 June 2026)
- Emerging Trends in Cell Therapy for Immune Complications Associated with Hematopoietic Cell Transplantation (Deadline: 31 July 2026)
- Role of Gene Regulation in Neurological Disorders (Deadline: 20 August 2026)
- Epigenetic Plasticity: How Chromatin Dynamics Orchestrate Fundamental Life Processes (Deadline: 30 August 2026)
- New Trends and Advances in Molecular Targeted Therapy for Cancers (Deadline: 31 August 2026)
- Gene and Cell Therapy in Regenerative Medicine—Third Edition (Deadline: 31 August 2026)
- The Silent Regulators: Non-Coding RNAs in Cell Function and Disease (Deadline: 25 September 2026)
- mRNA Regulation in Endoplasmic Reticulum Stress and Protein Homeostasis (Deadline: 30 September 2026)
- Interactions Between Gut Microbiota and Epigenetic Markers in Health and Disease (Deadline: 31 October 2026)
- MicroRNAs in Atherosclerosis: Mechanisms, Biomarkers, and Therapeutic Opportunities (Deadline: 31 October 2026)
- Molecular Genetics of Cystic Kidney Disease (Deadline: 31 October 2026)
- Epigenetic Regulation of Cellular Plasticity in Brain Tumors (Deadline: 31 October 2026)
- Mechanisms of Transcriptional Regulation in Disease: From Chromatin Dynamics to Therapeutic Innovation (Deadline: 30 November 2026)
- Genome Editing in Biomedicine (Deadline: 30 November 2026)
